Zofran Lawsuit Alleges Drug Caused Newborn’s Deformities

November 12, 2015 – – ZofranLegal.com reports on another lawsuit filed against anti-nausea medication Zofran and manufacturer GlaxoSmithKline. This lawsuit, filed by a mother in Idaho, alleges that exposure to the drug while developing in utero caused her newborn to be deformed. The suit was filed in the U.S. District Court in Idaho and requests compensation from GlaxoSmithKline for surgeries necessary to attempt to repair some of the baby’s deformities.

The woman’s daughter was born with a condition called amniotic band constriction, and teratologic clubfoot deformities as well. These conditions will affect the proper development of her limbs, hands, and feet. The lawsuit indicates that GSK knowingly concealed the birth defect risks associated with their drug and that the child would never have developed these injuries if not exposed to Zofran while developing in utero.

Zofran was approved by the U.S. Food and Drug Administration, but, interestingly enough, it was never approved to treat pregnant mothers and morning sickness, and was never tested for safety in this aspect either. The FDA approved the drug specifically to treat individuals who had undergone chemotherapy, radiation, or anesthesia and who were battling severe nausea and vomiting because of that. Despite this fact, GSK allegedly marketed the drug to the medical community, general public, and OB/Gyns to treat morning sickness. The drug has since been prescribed “off-label” to many women.

Multiple studies seem to support the allegations linking Zofran use in pregnant mothers to an increased risk of babies born with birth defects. More than 60 similar lawsuits, alleging that the drug caused various birth defects support the same claim. Most commonly noted defects include cleft lip and palate, atrial and ventricular septal defect, transposition of the greater vessels, tetralogy of fallot, clubfoot, and kidney defects.

These suits have been consolidated by the U.S. Judicial Panel on Multidistrict Litigation. It is hoped that this will help to speed up the litigation process, conserve time and money for those involved, and avoid duplicate discovery.

As these cases await trial, it is expected that others will continue to be filed. The attorneys at Monheit Law are working to help ensure that anyone who was given Zofran during pregnancy and who later gave birth to a baby with defects is able to explore their legal rights. It is possible that these individuals and their children are entitled to compensation. Michael Monheit, Esq. is offering free consultations for those involved at this time.

To obtain additional information on this topic, or to ask questions, contact Michael Monheit, Esq. by calling 877-620-8411.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60005369